日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Prescriber- and Patient-Level Characteristics Associated with Patient Adherence to Any Antipsychotics Among Patients with Schizophrenia in the United States

美国精神分裂症患者抗精神病药物依从性相关的处方医生和患者层面特征

期刊:Patient Preference and Adherence
影响因子:2
doi:10.2147/PPA.S570441
Voegel, Arthur; Naranjo, Ronaldo R Jr; Diaz, Lilian; Vanden Eynde, Claire; Wang, Yuxi; Pilon, Dominic; Benson, Carmela; Citrome, Leslie
精神分裂症
神经科学
发表日期：2026
文献求助 收藏

The Clinically Meaningful Score Difference and Meaningful Score Regions in Positive and Negative Syndrome Scale Total Score from Post Hoc Analyses of a Phase 3 Pivotal Clinical Trial of Transdermal Asenapine in Patients with Schizophrenia

精神分裂症患者经皮阿塞那平治疗的3期关键性临床试验事后分析中阳性和阴性症状量表总分的临床意义评分差异和有意义评分区域

期刊:
影响因子:
doi:10.2147/NDT.S562499
Citrome, Leslie; Czobor, Pál; Komaroff, Marina; Khan, Mahwish; Hasebe, Masami; Terahara, Takaaki
精神分裂症
神经科学
发表日期：2026
文献求助 收藏

Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis

达里多雷生、伦博雷生和苏沃雷生治疗失眠的疗效和安全性比较：系统评价和网络荟萃分析

期刊:Translational Psychiatry
影响因子:6.2
doi:10.1038/s41398-025-03439-8
Kishi, Taro; Ikuta, Toshikazu; Citrome, Leslie; Sakuma, Kenji; Hatano, Masakazu; Hamanaka, Shun; Nishii, Yasufumi; Iwata, Nakao
发表日期：2025
文献求助 收藏

The Use of Long-Acting Injectables for People with Schizophrenia: Consensus Panel Recommendations for Overcoming Barriers and Implementing Treatment

长效注射剂在精神分裂症患者中的应用：专家组关于克服障碍和实施治疗的共识建议

期刊:Neurology and Therapy
影响因子:4.8
doi:10.1007/s40120-025-00838-3
Kane, John M; Agid, Ofer; Castle, David J; Citrome, Leslie; Fagiolini, Andrea; Kishimoto, Taishiro; Larrauri, Carlos A; Leucht, Stefan; Rubio, Jose M; Sajatovic, Martha; Schooler, Nina; Correll, Christoph U
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Author Correction: Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials

作者更正：沙诺美林和托吡氯铵治疗精神分裂症的疗效：来自三项为期 5 周的随机、双盲、安慰剂对照 EMERGENT 试验的汇总结果

期刊:npj Schizophrenia
影响因子:4.1
doi:10.1038/s41537-025-00595-0
Kaul, Inder; Sawchak, Sharon; Claxton, Amy; Sauder, Colin; Hassman, Howard H; Kakar, Rishi; Walling, David P; Citrome, Leslie; Zhu, Haiyuan; Miller, Andrew C; Brannan, Stephen K
ERG
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes

致美国食品药品监督管理局（FDA）的信函：提议对美国氯氮平药品说明书进行重大修改，该提议得到了全球氯氮平专家的支持。第一部分：药代动力学文献综述及拟议修改

期刊:Journal of Clinical Psychopharmacology
影响因子:2.8
doi:10.1097/JCP.0000000000001987
de Leon, Jose; Baldessarini, Ross J; Balon, Richard; Bilbily, John; Caroff, Stanley N; Citrome, Leslie; Correll, Christoph U; Cotes, Robert O; Davis, John M; DeLisi, Lynn E; Faden, Justin; Freudenreich, Oliver; Goldsmith, David R; Gurrera, Ronald; Josiassen, Richard C; Kane, John M; Kelly, Deanna L; Keshavan, Matcheri S; Laitman, Robert S; Lam, Y W Francis; Leung, Jonathan G; Love, Raymond C; McCollum, Betsy; McGrane, Ian R; Meyer, Jonathan; Nasrallah, Henry A; Nucifora, Frederick C Jr; Rothschild, Anthony J; Rubio, Jose M; Sajatovic, Martha; Sarpal, Deepak K; Schoretsanitis, Georgios; Shad, Mujeeb; Shelton, Charles; Sher, Leo; Singh, Balwinder; Surya, Sandarsh; Zarzar, Theodore R; Sanz, Emilio J; De Las Cuevas, Carlos
发表日期：2025
文献求助 收藏

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes

致FDA的信函：提议对美国氯氮平药品说明书进行重大修改，该提议得到了全球氯氮平专家的支持。第二部分：回顾美国药物警戒数据中的致命后果及拟议修改。

期刊:Journal of Clinical Psychopharmacology
影响因子:2.8
doi:10.1097/JCP.0000000000001990
de Leon, Jose; Baldessarini, Ross J; Balon, Richard; Bilbily, John; Caroff, Stanley N; Citrome, Leslie; Correll, Christoph U; Cotes, Robert O; Davis, John M; DeLisi, Lynn E; Faden, Justin; Freudenreich, Oliver; Goldsmith, David R; Gurrera, Ronald; Josiassen, Richard C; Kane, John M; Kelly, Deanna L; Keshavan, Matcheri S; Laitman, Robert S; Lam, Y W Francis; Leung, Jonathan G; Love, Raymond C; McCollum, Betsy; McGrane, Ian R; Meyer, Jonathan M; Nasrallah, Henry A; Nucifora, Frederick C Jr; Rothschild, Anthony J; Rubio, Jose M; Sajatovic, Martha; Sarpal, Deepak K; Schoretsanitis, Georgios; Shad, Mujeeb; Shelton, Charles; Sher, Leo; Singh, Balwinder; Surya, Sandarsh; Zarzar, Theodore R; Sanz, Emilio J; De Las Cuevas, Carlos
发表日期：2025
文献求助 收藏

The specific anti-hostility effect of lurasidone in patients with an acute exacerbation of schizophrenia: results of pooled post hoc analyses in adolescents and adults

鲁拉西酮对急性精神分裂症患者特有的抗敌意作用：青少年和成人汇总事后分析结果

期刊:International Clinical Psychopharmacology
影响因子:2.5
doi:10.1097/YIC.0000000000000563
Citrome, Leslie; Álvarez-Barón, Elena; Gabarda-Inat, Irene; Thangavelu, Karthinathan; Tocco, Michael
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Preclinical Evidence for the Use of Brexpiprazole + Antidepressant Treatment for Major Depressive Disorder and Post-Traumatic Stress Disorder: A Systematic Review

Brexpiprazole联合抗抑郁药治疗重度抑郁症和创伤后应激障碍的临床前证据：系统评价

期刊:
影响因子:
doi:10.2147/NDT.S501207
Brubaker, Malaak; Kapadia, Shivani; Maletic, Vladimir; Chambers, Jessie S; Watling, Christopher P; Citrome, Leslie
创伤后应激障碍
抑郁症
神经科学
发表日期：2025
文献求助 收藏

Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed

Xanomeline 和托吡氯铵与安慰剂治疗精神分裂症的比较：治疗所需人数、伤害所需人数以及获益或受损可能性的事后分析

期刊:
影响因子:
doi:10.2147/NDT.S503494
Citrome, Leslie; Neugebauer, Nichole M; Meli, Alicia A; Kando, Judith
精神分裂症
神经科学
发表日期：2025
文献求助 收藏